Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucose absorption refers to the process by which glucose, a primary energy source, is transported from the lumen of the small intestine into enterocytes (intestinal epithelial cells) and then into the bloodstream. This process is essential for providing energy to body tissues and maintaining blood glucose homeostasis. The main mechanism involves SGLT1 (Sodium-Glucose Linked Transporter 1) for active transport and GLUT2 (Glucose Transporter Type 2) for facilitated diffusion. Regulation involves membrane potential and intracellular calcium levels. Defects can result in malabsorption syndromes, while modulation has therapeutic potential for obesity and diabetes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucose Absorption.